Tenascin C and annexin II expression in the process of pancreatic carcinogenesis
- 31 January 2006
- journal article
- research article
- Published by Wiley in The Journal of Pathology
- Vol. 208 (5) , 673-685
- https://doi.org/10.1002/path.1935
Abstract
Tenascin C (TNC) is a component of the provisional extracellular matrix (ECM) that characterizes solid tumours. Cell surface annexin II is a high‐affinity receptor for large TNC splice variants. The aim of this study was to analyse whether TNC and annexin II play a role in the development of pancreatic ductal adenocarcinoma (PDAC). PDAC is characterized by a rich ECM populated by pancreatic stellate cells, which play a crucial role in pancreatic desmoplasia. The mRNA and protein levels of TNC and of annexin II were analysed in pancreatic tissues by DNA array, quantitative reverse transcriptase‐polymerase chain reaction (QRT‐PCR) and immunohistochemistry. TNC large splice variants were detected by RT‐PCR. Enzyme linked immunosorbent assay (ELISA) was used to measure TNC levels in serum and culture supernatants. TNC and annexin II mRNA levels were significantly higher in pancreatic cancer tissues than in the normal pancreas. TNC expression was detected with increased frequency in the progression from PanIN‐1 lesions to PDAC, and a parallel switch from cytoplasmic to cell surface expression of annexin II was observed. Large TNC transcripts were found in pancreatic cancer and in chronic pancreatitis, but not in the normal pancreas. TNC expression was demonstrated in pancreatic stellate cells, where it could be induced by tumour necrosis factor α (TNFα), transforming growth factor β1 (TGF‐β1) and by cancer cell supernatants supplemented with TGF‐β1. In conclusion, the expression of TNC and cell surface annexin II increases in the progression from low‐grade PanIN lesions to pancreatic cancer. Pancreatic stellate cells are identified as a source of TNC in pancreatic tissues, possibly under the influence of soluble factors released by the tumour cells. Copyright © 2006 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.Keywords
This publication has 39 references indexed in Scilit:
- Nuclear annexin II negatively regulates growth of LNCaP cells and substitution of ser 11 and 25 to glu prevents nucleo-cytoplasmic shuttling of annexin IIBMC Biochemistry, 2003
- Cancer Statistics, 2003CA: A Cancer Journal for Clinicians, 2003
- Pancreatic cancer biology and geneticsNature Reviews Cancer, 2002
- Syndecan-1 expression is up-regulated in pancreatic but not in other gastrointestinal cancersInternational Journal of Cancer, 2000
- The tenascin family of ECM glycoproteins: Structure, function, and regulation during embryonic development and tissue remodelingDevelopmental Dynamics, 2000
- The cell-surface heparan sulfate proteoglycan glypican-1 regulates growth factor action in pancreatic carcinoma cells and is overexpressed in human pancreatic cancer.Journal of Clinical Investigation, 1998
- Extracellular annexin IIThe International Journal of Biochemistry & Cell Biology, 1997
- Expression and Function of Receptors for Extracellular Matrix Proteins in Human Ductal Adenocarcinomas of the PancreasPancreas, 1996
- Cell surface annexin II is a high affinity receptor for the alternatively spliced segment of tenascin-C.The Journal of cell biology, 1994
- Enhanced expression of annexin II in human pancreatic carcinoma cells and primary pancreatic cancersCarcinogenesis: Integrative Cancer Research, 1993